Christian Tovar
- Oncology top 1%
- Cancer-related Molecular Pathways 20
- Cell Biology top 2%
- Microtubule and mitosis dynamics 8
- Molecular Biology top 5%
- Ubiquitin and proteasome pathways 12
- Cancer therapeutics and mechanisms 2
- Biotechnology top 2%
- Cancer Research and Treatments 3
- Cancer Research top 5%
- Cancer, Hypoxia, and Metabolism 2
-
- Click Chemistry and Applications 2
-
- Cancer Mechanisms and Therapy 2
- Co-authors
- David HeimbrookLyubomir T. VassilevKathryn PackmanBinh Thanh VuXiaolan ZhaoZoran FilipovicDejan KnezevicBrian Higgins
- Journals
- Cancer Research (4 papers)Molecular Cancer Therapeutics (3 papers)ACS Medicinal Chemistry Letters (3 papers)
- Partner nations
- United StatesSwitzerlandGermany
In The Last Decade
Christian Tovar
25 papers receiving 3.2k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.9k
- Cell Biology 610
- Molecular Biology 2.3k
- Biotechnology 268
- Cancer Research 356
Countries citing papers authored by Christian Tovar
This map shows the geographic impact of Christian Tovar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christian Tovar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christian Tovar more than expected).
Fields of papers citing papers by Christian Tovar
This network shows the impact of papers produced by Christian Tovar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christian Tovar. The network helps show where Christian Tovar may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Christian Tovar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 49 | |
| 2 | 2014 | 50 | |
| 3 | Colangiopancreatografía magnética: valor diagnóstico para detectar coledocolitiasis en pacientes con pancreatitis aguda leve | 2014 | 0 |
| 4 | 2014 | 42 | |
| 5 | 2013 | 220 | |
| 6 | Discovery of RG7388, a Potent and Selective p53–MDM2 Inhibitor in Clinical Developmentbreakdown → | 2013 | 447 |
| 7 | 2013 | 3 | |
| 8 | 2013 | 17 | |
| 9 | 2012 | 3 | |
| 10 | 2012 | 188 | |
| 11 | 2011 | 10 | |
| 12 | 2011 | 36 | |
| 13 | 2010 | 24 | |
| 14 | 2008 | 39 | |
| 15 | 2008 | 62 | |
| 16 | 2007 | 50 | |
| 17 | Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapybreakdown → | 2006 | 553 |
| 18 | Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1breakdown → | 2006 | 620 |
| 19 | Development and characterization of a pre-clinical model of ovarian carcinoma to investigate mechanisms of resistance to the anti-HER2/neu antibody Herceptin™ | 2004 | 1 |
| 20 | 2004 | 198 |
About Christian Tovar
Christian Tovar is a scholar working on Oncology, Cell Biology and Biotechnology, having authored 26 papers that have together received 3.2k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (20 papers), Ubiquitin and proteasome pathways (12 papers), Microtubule and mitosis dynamics (8 papers), Cancer Research and Treatments (3 papers), Cancer therapeutics and mechanisms (2 papers), Click Chemistry and Applications (2 papers), Cancer Mechanisms and Therapy (2 papers) and Cancer, Hypoxia, and Metabolism (2 papers). The work is most often cited by research in Oncology (1.9k citations), Cell Biology (610 citations) and Molecular Biology (2.3k citations). Christian Tovar has collaborated with scholars based in United States, Switzerland and Germany. Frequent co-authors include David Heimbrook, Lyubomir T. Vassilev, Kathryn Packman, Binh Thanh Vu, Xiaolan Zhao, Lyubomir T. Vassilev, Zoran Filipovic, Dejan Knezevic, Brian Higgins and Bradford Graves. Their work appears in journals such as Cancer Research, Molecular Cancer Therapeutics, ACS Medicinal Chemistry Letters, Proceedings of the National Academy of Sciences and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.